BAUDAX BIO INC (BXRX)

US07160F4046 - Common Stock

0.1864  +0 (+0.59%)

After market: 0.17 -0.02 (-8.8%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

MRQ
(2023-6-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
ASSETS
Current Assets
Cash Equivalents
1.42M5.26M15.89M30.34M17.74M
Receivables
N/A340.00K540.00K50.00KN/A
Inventories
N/A0.005.00M2.98MN/A
Other Current Assets
440.00K750.00K2.06M3.35M2.40M
Total Current Assets
1.86M6.35M23.49M36.72M20.14M
 
Non-Current Assets
PPE Net
6.72M1.56M5.98M5.64M5.55M
Goodwill
9.24M2.13M2.13M2.13M2.13M
Intangibles
3.50M0.0021.68M24.25M26.40M
Other Non-Current Assets
0.00N/AN/AN/AN/A
Total Non-Current Assets
19.46M3.68M29.79M32.01M34.07M
 
TOTAL ASSETS
21.32M10.03M53.28M68.73M54.21M
 
LIABILITIES
Current Liabilities
Short Term Debt
1.00M0.000.000.000.00
Current Portion Of LT Debt.
4.86M5.60M2.22M680.00KN/A
Accrued Expenses
2.57M1.80M4.70M4.44M2.50M
Accounts Payable
5.83M3.93M1.47M3.65M270.00K
Other Current Liabilities
6.20M10.13M7.25M9.36M4.94M
Total Current Liabilities
20.46M21.46M15.65M18.13M7.71M
 
Non-Current Liabilities
Long Term Debt
0.001.52M6.31M8.47M0.00
Deferred Taxes/Income
200.00KN/AN/AN/AN/A
Other Non-Current Liabilities
2.30M11.30M18.10M56.93M63.22M
Total Non-Current Liabilities
2.50M12.81M24.40M65.40M63.22M
 
TOTAL LIABILITIES
22.96M34.27M40.05M83.53M70.93M
 
SHAREHOLDERS' EQUITY
Retained Earnings
-186.88M-190.90M-132.09M-112.32M-36.22M
Additional Paid In Capital
176.13M166.65M144.33M97.03M19.41M
Common Shares
9.11M20.00K980.00K490.00K90.00K
Shares Outstanding
6.96M1.62M70.00K30.00K10.00K
Tangible Book Value per Share
-3.36-16.28-151.14-1.37K-4.53K
Total Shareholders' Equity
-1.64M-24.24M13.23M-14.80M-16.72M
 
TOTAL LIABILITIES AND EQUITY
21.32M10.03M53.28M68.73M54.21M
 
Statistics
Debt/Equity
N/A-0.060.48-0.57N/A
Current Ratio
0.090.301.502.032.61
Return On Assets (ROA)
-161.54%-586.24%-41.65%-110.72%-60.06%
Return On Equity (ROE)
N/AN/A-167.72%N/AN/A

All data in USD

Charts